Robert J. Broersma

402 total citations
21 papers, 299 citations indexed

About

Robert J. Broersma is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert J. Broersma has authored 21 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert J. Broersma's work include Chemical Synthesis and Analysis (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Platelet Disorders and Treatments (3 papers). Robert J. Broersma is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Platelet Disorders and Treatments (3 papers). Robert J. Broersma collaborates with scholars based in United States and Spain. Robert J. Broersma's co-authors include Eberhard Mammen, J.C. Rosenberg, John L. Krstenansky, B. Rosenberg, Thomas J. Owen, Simon J.T. Mao, Mark T. Yates, James R. McCarthy, Thomas M. Bargar and Bernhard Neises and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Robert J. Broersma

21 papers receiving 264 citations

Peers

Countries citing papers authored by Robert J. Broersma

Since Specialization

Citations

This map shows the geographic impact of Robert J. Broersma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Broersma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Broersma more than expected).

Fields of papers citing papers by Robert J. Broersma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Broersma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Broersma. The network helps show where Robert J. Broersma may publish in the future.

Co-authorship network of co-authors of Robert J. Broersma

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Broersma. A scholar is included among the top collaborators of Robert J. Broersma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Broersma. Robert J. Broersma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Narrow-bore liquid chromatography-tandem mass spectrometry with simultaneous radioactivity monitoring for partially characterizing the biliary metabolites of an arginine fluoroalkyl ketone analog of d-MePhe-Pro-Arg, a potent thrombin inhibitor 1997 ·Journal of Chromatography B Biomedical Sciences and Applications ·Timothy G. Heath, (unknown), Robert J. Broersma	7
2	Molecular Design and Characterization of an α-Thrombin Inhibitor Containing a Novel P1 Moiety 1997 ·Biochemistry ·(unknown), Joseph P. Burkhart, Herman Schreuder, Robert J. Broersma, Chantal Tardif, (unknown), Shujaath Mehdi, Gerald L. Schatzman, Bernhard Neises, Norton P. Peet	24
3	Synthesis and comparison of tripeptidylfluoroalkane thrombin inhibitors 1995 ·Bioorganic & Medicinal Chemistry ·Bernhard Neises, Robert J. Broersma, Céline Tarnus, François Piriou, (unknown), (unknown), (unknown), (unknown)	15
4	Synthesis of a 2,5‐diaryloxazoline as a potential platelet‐activating factor antagonist 1994 ·Journal of Heterocyclic Chemistry ·Norton P. Peet, Joseph P. Burkhart, Robert J. Broersma, (unknown)	4
5	The Synthesis and Anticoagulant Activity of Novel Peptidylfluoroalkanes 1993 ·Advances in experimental medicine and biology ·Bernhard Neises, Céline Tarnus, Robert J. Broersma, (unknown), (unknown), (unknown)	5
6	The effect of thrombin inhibition in a rat arterial thrombosis model 1991 ·Thrombosis Research ·Robert J. Broersma, (unknown), (unknown)	23
7	Antithrombotic Activity of a Novel C-Terminal Hirudin Analog in Experimental Animals 1991 ·Thrombosis and Haemostasis ·Robert J. Broersma, (unknown), (unknown), John L. Krstenansky, (unknown)	16
8	1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine .beta.-hydroxylase 1990 ·Journal of Medicinal Chemistry ·James R. McCarthy, Donald P. Matthews, Robert J. Broersma, (unknown), Philip R. Kastner, Jean‐Marie Hornsperger, David A. Demeter, Herschel J. R. Weintraub, Jeffrey P. Whitten	6
9	Development of MDL 28,050, a Small Stable Antithrombin Agent Based on a Functional Domain of the Leech Protein, Hirudin 1990 ·Thrombosis and Haemostasis ·John L. Krstenansky, Robert J. Broersma, Thomas J. Owen, (unknown), Mark T. Yates, Simon J.T. Mao	41
10	Pharmacological profile of 8-amino octanoic acid substituted atrial natriuretic factor analogs 1988 ·Biochemical and Biophysical Research Communications ·C. Fred Hassman, John T. Pelton, Stephen H. Buck, (unknown), (unknown), Robert J. Broersma, Judd Berman	5
11	Design and synthesis of metabolically stable atrial natriuretic factor analogs 1988 ·FEBS Letters ·Judd Berman, Teng‐Man Chen, Roger G. Sargent, Stephen H. Buck, (unknown), (unknown), Robert J. Broersma	2
12	Highly effective mechanism-based inactivation of dopamine .beta.-hydroxylase by a novel ketene thioacetal 1988 ·Journal of the American Chemical Society ·Thomas M. Bargar, Robert J. Broersma, Lawrence C. Creemer, James R. McCarthy, (unknown), Paul V. Attwood, Michel J. Jung	4
13	Synthesis and activity of partial retro‐inverso modified atrial natriuretic factor analogs 1988 ·International journal of peptide & protein research ·Judd Berman, John T. Pelton, C. Fred Hassman, Stephen H. Buck, (unknown), (unknown), (unknown), Robert J. Broersma	3
14	Unsaturated heterocyclic amines as potent time-dependent inhibitors of dopamine .beta.-hydroxylase 1986 ·Journal of Medicinal Chemistry ·Thomas M. Bargar, Robert J. Broersma, Lawrence C. Creemer, James R. McCarthy, (unknown), Michael G. Palfreyman, Joseph E. Wagner, Michel J. Jung	39
15	6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-Phenoxycylopentyl)amino]methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel .alpha.1-adrenergic receptor antagonist and renal vasodilator 1985 ·Journal of Medicinal Chemistry ·James R. McCarthy, Mark Zimmerman, (unknown), Michael E. LeTourneau, (unknown), Jeffrey P. Whitten, Robert J. Broersma, (unknown), Norbert L. Wiech, John C. Huffman	2
16	The Determination of Platelet Aggregation by Filtration Pressure in Circulating Dog Blood 1973 ·Thrombosis and Haemostasis ·Robert J. Broersma, (unknown), (unknown)	3
17	Detection of antibodies to transplantation antigens by platelet aggregometry 1971 ·Journal of Surgical Research ·Robert J. Broersma, Eberhard Mammen, (unknown), J.C. Rosenberg	3
18	Acidosis Induced Disseminated Intravascular Microthrombosis and its Dissolution by Streptokinase 1970 ·Thrombosis and Haemostasis ·Robert J. Broersma, (unknown), Eberhard Mammen	26
19	Blood coagulation changes in hemorrhagic shock and acidosis. 1969 ·PubMed ·Robert J. Broersma, (unknown), Eberhard Mammen	10
20	RELATIONSHIP OF PLATELETS, BLOOD COAGULATION, AND FIBRINOLYSIS TO HYPERACUTE REJECTION OF RENAL XENOGRAFTS 1969 ·Transplantation ·J.C. Rosenberg, Robert J. Broersma, (unknown), Eberhard Mammen, (unknown), B. Rosenberg	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact